Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of BGM1812 Injection

About this update from Brightgene Bio-medical Technology Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of BGM1812 InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Brightgene Bio-medical Technology Co. Ltd. Class A